Source link : https://www.newshealth.biz/health-news/what-role-should-genomic-classifier-testing-play-in-prostate-cancer/
Genomic classifier (GC) tests do not appear to consistently influence risk classification or treatment decisions for patients with newly diagnosed prostate cancer considering first-line treatment, according to results from a systematic review. Among 10 studies reporting risk reclassification after GC testing with one of three available tests — Decipher, Prolaris, or the Oncotype DX Genomic […]
Author : News Health
Publish date : 2025-01-20 22:00:00
Copyright for syndicated content belongs to the linked Source.